Evidence map›Paper›PMID 42613837›Full record

ArticleHGG advances2026

Underrepresented voices in a Colorado Biobank: Perspectives from focus groups on motivations, return of results, and data sharing.

Carissa A Sherman, Betzaida L Maldonado, Lucas O Rozell, Sarah D Slack, Isabella E Eaton, Doreen E Martinez, Randi K Johnson, Katrina G Claw

Abstract read
In one paragraph

Article in HGG advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carissa A ShermanDepartment of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO, USA.
Betzaida L MaldonadoDepartment of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO, USA.
Lucas O RozellDepartment of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO, USA.
Sarah D SlackDepartment of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO, USA.
Isabella E EatonDepartment of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO, USA.
Doreen E MartinezDepartment of Race, Gender and Ethnic Studies, College of Liberal Arts, Colorado State University, Fort Collins, CO, USA.
Randi K JohnsonDepartment of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO, USA; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA.
Katrina G ClawDepartment of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO, USA. Electronic address: katrina.claw@cuanschutz.edu.

Funding

Pharmacogenomic approaches to drug metabolism in American Indian/Alaska Native PeopleR35HG011319 · NHGRI · UNIVERSITY OF COLORADO DENVER · PI CLAW, KATRINA G · 2020 to 2024
$2.9M
NHGRI NIH HHS R35 HG011319
6 · The paper itself

Abstract

Most participants in large cohorts, such as biobanks, are of European descent. This lack of representation has been an ongoing challenge in genomic research. Understanding the perspectives on genomics research and participation in biobanks of historically underrepresented populations could provide insight into ways to better engage with these groups. We conducted a series of virtual and in-person focus groups with individuals who self-identified as American Indian or Alaska Native (AI/AN), African American/Black (AA/B), or Hispanic/Latino (H/L) and who were enrolled in the Colorado Center for Personalized Medicine (CCPM) biobank. The focus group discussions were centered on participant experiences, including but not limited to their motivations, return of results, and data sharing. There was a total of 23 participants across the six focus groups. The majority of participants identified as AI/AN (60.9%), followed by H/L (39.1%), and AA/B (21.7%); many participants identified with multiple race/ethnicities. The motivations for participating in the biobank included the potential to advance science and health, the potential for return of results, to learn more about one's ancestry, and a few indicated that they were interested in helping the biobank be more representative of all populations. Notably, many expressed positive feedback of the focus groups and felt that their views were valued, illustrating the importance of community-centered work. Our findings can be used to guide recruitment and engagement of biobank participants, especially from diverse backgrounds, contributing to enhanced partnerships advancing knowledge and healthcare.

Indexed as

Biological Specimen BanksInformation DisseminationMotivationAdultColoradoFemaleFocus GroupsHumansMaleMiddle AgedReturn of Individual Research Resultsbiobankdiverse populationsengagementfocus groupsgenetics research

Identifiers

PMID42613837
PMCPMC13582004

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.